Optomed Q4: Quarter in line with expectations - Redeye

Redeye provides an update following Optomed’s Q4 report. The report fairly aligned with our expectations as sales were in line with our estimate. However, we make some downward sales estimate changes throughout our forecast and incorporate a new WACC, rendering an updated fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1077026/optomed-q4-quarter-in-line-with-expectations?utm_source=finwire&utm_medium=RSS